Stayble's CEO, Andreas Gerward, presented (in Swedish) at Financial Stockholm on December 11, 2024
Stayble Therapeutics AB ("Stayble" or "the Company") CEO, Andreas Gerward, presented (in Swedish) the Company, the results from phase 1b, and the path forward at Financial Stockholm's event "Invest Like the Pros" on December 11, 2024. Watch the recorded presentation below:https://www.youtube.com/watch?v=41H9eQ57mlc For more information Andreas Gerward, CEO of Stayble Therapeutics AB Mail: andreas.gerward@stayble.se Phone: +46 730 808 397 About Stayble Therapeutics AB Stayble is a clinical pharmaceutical company developing the injection treatment STA363 for